| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.0004 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.5 | 0.0006 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.003 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.004 |